Erythrocyte abnormalities in alpha-1-antitrypsin deficiency (AATD) patients

H. Ward, R. A. Stockley (Birmingham, United Kingdom)

Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Session: COPD: exacerbation and clinical problems
Session type: Thematic Poster Session
Number: 3477
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Ward, R. A. Stockley (Birmingham, United Kingdom). Erythrocyte abnormalities in alpha-1-antitrypsin deficiency (AATD) patients. Eur Respir J 2009; 34: Suppl. 53, 3477

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ)
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006

Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD.
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study
Source: Eur Respir J 2005; 26: Suppl. 49, 361s
Year: 2005

Severe alpha-1-antitrypsin deficiency (A1ATD) caused by Q0Ourém mutation: A clinical characterization
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010

Characterization of a population of alpha1-antitrypsin deficient (A1ATD) patients
Source: Annual Congress 2008 - COPD
Year: 2008


Gas exchange is an independent predictor for macrocytosis in alpha-1-antitrypsin deficiency (AATD)
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009

Alpha 1 antitrypsin (A1AT) deficiency among patients with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 501s
Year: 2003

Aα360: A measure of disease and treatment efficacy in alpha-1-antitrypsin (A1AT) deficiency
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010

Young adult with inherited PiMZ alpha-1-antitrypsin deficiency (A1ATD)-related bronchiectasis: characteristic of blood neutrophils and A1AT protein
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016


Occupational exposure in alpha-1-antitrypsin deficiency (AATD)
Source: Annual Congress 2008 - COPD and other environment-related lung diseases
Year: 2008

Proteinase 3 activity is present in sputum from subjects with alpha-1-antitrypsin deficiency (AATD) and COPD
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012

Effect of danazol on acute phase reactants in patients with PiM, PiMZ and PiZ phenotypes for alpha-1-antitrypsin deficiency
Source: Eur Respir J 2001; 18: Suppl. 33, 249s
Year: 2001

Alpha-1-antitrypsin deficiency patients (AATD): two-year follow-up
Source: Eur Respir J 2002; 20: Suppl. 38, 260s
Year: 2002

Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD)
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010


Alpha-1-antitrypsin deficiency
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=139
Year: 2005

Bronchiectasis in alpha1-antitrypsin deficiency
Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions
Year: 2019


Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


a1-antitrypsin deficiency
Source: Eur Respir Monogr 2015; 69: 47-84
Year: 2015